Pharma cold chain buyer hub — decisions, documents, contacts and project brief
Everything a pharmaceutical buyer settles before a supplier is contacted: duty and temperature bands, regulatory regime, redundancy level, installation boundary and one shared exclusions sheet. Send the brief below and a person reviews it, structures the RFQ and only then researches suppliers. All figures on this page are planning ranges from comparable anonymised projects — never quotations, never contractor recommendations.
Six decisions that make pharma bids comparable
| Buyer step | What you decide | Why bids stay incomparable without it |
|---|---|---|
| 1. Duty and temperature bands | Volume per zone, set points and tolerances, design ambient and humidity, product load profile | Every bidder assumes a different load, so headline prices diverge by 25–35% before scope is even discussed |
| 2. Regulatory regime | GDP, GMP or WHO PQS expectations, qualification split, mapping campaigns, data-integrity level | Validation is the largest hidden cost line in pharma bids and the easiest for a bidder to leave out |
| 3. Resilience level | N+1 or 2N per zone, standby power, hold time on outage, alarm escalation | Redundancy silently doubles plant cost; unstated, it becomes a variation after award |
| 4. Installation boundary | Who does civils, HV, drainage, gas detection, commissioning attendance and training | Interface scope is where two otherwise identical bids separate |
| 5. One exclusions sheet | A single annex every bidder prices and signs against | Re-pricing exclusions on one scope typically narrows a 25–35% spread to 10–12% |
| 6. Managed introduction | ColdMatch reviews the brief, structures the RFQ, then introduces qualified suppliers manually | No automatic matching: nothing reaches a manufacturer before a person has read the project |
Documents the tender pack needs
| Document | What it must state | Stage |
|---|---|---|
| User requirement specification | Zones, set points, tolerances, capacity, regulatory regime, monitoring expectations | Before any supplier contact |
| Heat-load basis | Design ambient and humidity, infiltration, product pull-down, selection software output | Before RFQ issue |
| Scope and exclusions annex | Line-by-line inside/outside scope, signed by each bidder | Issued with the RFQ |
| Qualification plan | DQ/IQ/OQ/PQ ownership, mapping protocol, acceptance criteria | Issued with the RFQ |
| Commercial schedule | Milestones, bonds, retention, warranty, spares, response times | Issued with the RFQ |
| Bid comparison sheet | All bids normalised onto one scope with exclusions re-priced | After bids return |
Talk to the ColdMatch desk
ColdMatch Group is part of Global B2B Group. Enquiries are answered by the sourcing desk; nothing is passed to a manufacturer before the brief has been reviewed with you.
Send your pharma cold chain brief
Short form — whatever you already know is enough. A person reviews every brief by hand, replies by email, and only researches suppliers after the scope is agreed with you.
Pharma buyer FAQs
What is a pharma cold chain buyer hub for?
It is the buyer-side entry point for a pharmaceutical cold storage or distribution project: what to decide before contacting anyone, which documents make bids comparable, what the planning cost ranges look like, and how to reach ColdMatch. It is written for the buyer, not the supplier — ColdMatch does not rate, rank, certify or guarantee contractors.
What does a pharma cold chain project cost?
As planning ranges from comparable anonymised projects: USD 400,000–900,000 for a clinical-trial and ULT suite, USD 800,000–1.6M for a national vaccine store, USD 1.5–3.5M for a GDP distribution hub and USD 2–4M for an API plant cold storage extension. Refrigeration plant is usually 30–55% of CAPEX and EPC engineering, construction, commissioning and qualification 25–45%. These are not quotations.
How long does a pharma cold chain project take?
Typically five to twelve months from user requirement specification to qualified handover: two to six weeks on the URS and budget, four to eight weeks of tender and bid comparison, four to ten weeks of detailed design to the design-qualification gate, ten to twenty weeks of manufacture and shipping, then six to sixteen weeks of installation, IQ/OQ, mapping and handover.
Which project size does ColdMatch work on?
Projects with an expected value from about USD 250,000 upwards. Smaller enquiries are still answered, but the structured RFQ and supplier-introduction process is built around industrial and commercial scale.
Does ColdMatch sell my details to manufacturers?
No. Nothing is shared with a manufacturer before a person at ColdMatch has read the brief and agreed the scope with you. There is no automatic marketplace, no lead selling and no paid ranking.
Can ColdMatch arrange financing for a pharma cold chain project?
Neither ColdMatch Group nor its parent Global B2B Group lends money or gives financial advice. Qualified projects may be introduced to independent financing partners; eligibility and terms are decided entirely by the institution concerned.
How do I speak to someone directly?
By WhatsApp or phone on +44 7936 808834, or by email to concierge@coldmatchgroup.com. Sending the project brief on this page first usually makes the call shorter, because the duty, temperature bands and installation scope are already written down.
Related pharma buyer reading
Supplier and manufacturer listings are provided for research, transparency and discovery only. ColdMatch Group does not provide automatic buyer-supplier introductions. Every cold chain project request is reviewed manually by David / ColdMatch Group, and supplier introductions are made only after internal approval.
Pharma buyer cluster: from duty figures to comparable bids
Buyer-side reference answers behind the anonymised ColdMatch case studies. All figures are planning ranges from comparable projects — not quotations and not contractor recommendations.
- How does a pharma buyer make cold storage bids comparable?
- Fix the design basis first — temperature bands, volume, design ambient, monitoring level and installation scope — then issue one RFQ annex every bidder prices against. On comparable anonymised projects, headline spreads of 25–35% fall to roughly 10–12% once exclusions are re-priced on one scope.
- What does a pharma buyer case study actually show?
- The situation before tender, the week-by-week tender programme, which calculators produced the specification figures, and the normalised outcome. Named clients, prices and contractors are never published; the record is anonymised and stated as a planning range.
- Which exclusions most often distort a pharma bid?
- HV coordination and standby power, machine-room gas detection, floor heating and condensate drainage, commissioning attendance, spare parts, and DQ/IQ/OQ/PQ qualification with temperature mapping. Requiring one common exclusion sheet is what makes bids readable.
- When should a pharma buyer contact suppliers?
- Only after the duty, temperature bands, GDP regime and installation scope are written down. The readiness check shows in minutes what is still missing; ColdMatch reviews each project — generally from about USD 250,000 expected value — and structures the RFQ before any outreach.
- Do food and logistics buyers follow the same route?
- Yes, with different duty drivers: ripening rooms and blast tunnels in food processing, door openings and multi-temperature zoning in distribution hubs. The sourcing method — model duty, fix scope, normalise exclusions — is identical.
- Does ColdMatch recommend a pharma contractor?
- No. ColdMatch Group is buyer-side: it does not rate, rank, certify or guarantee contractors, and introductions are made manually after a person reviews the project.